A new mega-merger deal was confirmed this week in the cannabis space.

Meanwhile, a Canadian cannabis producer announced more cuts to its operations, along with reductions in its staff, in a bid to improve its operational balance.


Keep reading to find out more cannabis highlights from the past five days.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Two cannabis producers announce intention to join forces

2020 was expected to be exemplified by mergers and acquisitions, and Aphria (NASDAQ:APHA,TSX:APHA) and Tilray (NASDAQ:TLRY) brought it down to the wire.

Under a newly announced merger deal, the two companies will join up, retaining the Tilray name and as well as Tilray’s stock symbol. However, Aphria CEO Irwin Simon will lead the entire operation, while Brendan Kennedy, CEO of Tilray, will become a board member.

According to estimations from the two companies, the resulting entity will hold a market valuation of C$5 billion and will post a combined C$900 million in pro forma revenue in 2020.

After the deal was confirmed, a panel of experts in the cannabis industry gathered to discuss the next steps for the market at large — but not before clamoring for more deals like the Aphria/Tilray tie up.

“(Tuesday’s) announcement is something that we’ve been suggesting for some time, (something) I think the industry needs and has been looking for, which is consolidation amongst the many operators that do sit in Canada,” Som Seif, founder and CEO of Purpose Financial, told an online audience.

The deal is expected to close sometime in Q2 of the 2021 calendar year.

Even more cuts seen in the Canadian cannabis space

A week after the latest round of cuts from cannabis producer Canopy Growth (NASDAQ:CGC,TSX:WEED), it is now Aurora Cannabis’ (NYSE:ACB,TSX:ACB) turn.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

An Aurora spokesperson confirmed to CBC that 214 workers will be dismissed for a proposed 75 percent reduction in operations at the company’s Aurora Sky facility in Edmonton, Alberta.

Miguel Martin, CEO of Aurora, said in a statement that some of the company’s previous cost-saving moves are already paying off. He said scaling back production at the Aurora Sky facility will make it so this space can transform into a “high-value cultivation center for our premium strains, and in turn, better align production with current demand for premium flower.”

After confirming an undisclosed agreement with its credit facility lenders, the company told investors that as of Tuesday (December 15) it held $450 million in cash.

Cannabis company news

  • Halo Labs (NEO:HALO,OTCQX:AGEEF) shared an update on a financing program through which the company sold 134,454,000 shares for gross proceeds of C$7 million.
  • Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) issued its Q3 financial results, highlighting C$1.2 million in positive adjusted EBITDA and sequential growth in revenue of 15.8 percent from the previous quarter.
  • VIVO Cannabis (TSX:VIVO,OTCQX:VVCIF) confirmed that a selection of its medical cannabis products in Canada are now available through the Medical Cannabis by Shoppers online platform.
  • AMP German Cannabis Group (CSE:XCX) sent a letter to shareholders evaluating its operating year highlights in the German cannabis market and what may be on the way in 2021.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 
  • The Cannabis Derivatives are derived from Avicanna’s cultivation and extraction infrastructure in Santa Marta, Colombia designed to supply partner companies and the manufacture of Avicanna’s own finished products.

Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that, through its majority owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. (“ SMGH ”), it has completed a commercial exports of CBD Isolate and CBD full spectrum psychoactive cannabis resin (the “ Cannabis Derivatives ”) to a leading Chilean homeopathic and naturopathic pharmaceutical company.

The Cannabis Derivatives, branded as Aureus™, are cultivated, extracted, and manufactured by SMGH. In addition, for Avicanna’s global input needs, SMGH also supplies other pharmaceutical and cosmetics companies with cannabinoids including CBD, THC, and rare cannabinoids such as CBG in addition to supplying global cultivation companies with standardized and feminized seeds. This new export to Chile is a recurring order and part of on-going relationship with an established homeopathic Chilean company.

Keep reading... Show less

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2022 ended September 30, 2021 before financial markets open on November 5, 2021 .

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary in Wyomissing, Pennsylvania. Wyomissing will be Cresco Labs’ fifth dispensary in Pennsylvania and 38 th nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211021006075/en/

Keep reading... Show less

The world of cannabis consumption is set to change radically, thanks in large part to the advancement of state-of-the-art research on the plant itself.

Medical cannabis products have already allowed many new users to discover the plant’s potential, but decisive research will help build a foundation for more sophisticated medical offerings.

Keep reading... Show less

ADASTRA HOLDINGS LTD. ENGAGES HYBRID FINANCIAL LTD.

Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) (“Adastra”, or the “Company”) is pleased to announce that it has retained Hybrid Financial Ltd. (“Hybrid”) to provide marketing services to the Company. Hybrid has been engaged to heighten market and brand awareness for Adastra and to broaden the Company’s reach within the investment community.

Keep reading... Show less